Indonesia's Bio Farma says Sinovac vaccine shows up to 97% efficacy against Covid-19

An official checks on Covid-19 vaccines from China's Sinovac Biotech Ltd. as they arrive at PT Bio Farma (Persero) in the first shipment to Indonesia in Bandung, West Java province, Indonesia, on Dec 7, 2020. - Reuters

JAKARTA (Reuters): Indonesia's state-owned pharmaceutical company Bio Farma said on Tuesday (Dec 8) that interim data on trials it was conducting on vaccines produced by the Chinese company Sinovac showed up to 97 per cent efficacy.

"Our clinical trial team found, within one month, that the interim data shows up to 97 per cent for its efficacy," said Iwan Setiawan, a spokesman for Bio Farma, at a news conference.